- Home
- Medical news & Guidelines
- Anesthesiology
- Cardiology and CTVS
- Critical Care
- Dentistry
- Dermatology
- Diabetes and Endocrinology
- ENT
- Gastroenterology
- Medicine
- Nephrology
- Neurology
- Obstretics-Gynaecology
- Oncology
- Ophthalmology
- Orthopaedics
- Pediatrics-Neonatology
- Psychiatry
- Pulmonology
- Radiology
- Surgery
- Urology
- Laboratory Medicine
- Diet
- Nursing
- Paramedical
- Physiotherapy
- Health news
- AYUSH
- State News
- Andaman and Nicobar Islands
- Andhra Pradesh
- Arunachal Pradesh
- Assam
- Bihar
- Chandigarh
- Chattisgarh
- Dadra and Nagar Haveli
- Daman and Diu
- Delhi
- Goa
- Gujarat
- Haryana
- Himachal Pradesh
- Jammu & Kashmir
- Jharkhand
- Karnataka
- Kerala
- Ladakh
- Lakshadweep
- Madhya Pradesh
- Maharashtra
- Manipur
- Meghalaya
- Mizoram
- Nagaland
- Odisha
- Puducherry
- Punjab
- Rajasthan
- Sikkim
- Tamil Nadu
- Telangana
- Tripura
- Uttar Pradesh
- Uttrakhand
- West Bengal
- Medical Education
- Industry
Delhi HC rejects plea seeking reduction in dosage interval of Covishield
Delhi: The Delhi High Court on Thursday dismissed a plea seeking reduction of the interval for the second dose of Covishield vaccine to eight weeks for individuals over 50 years of age and those having comorbidities. The gap between two doses of Covishield vaccine is presently 12 to 16 weeks.The PIL was filed by Dr Siddharth De through Advocate Kuldeep Jauhari.However, a bench of Chief Justice...
Delhi: The Delhi High Court on Thursday dismissed a plea seeking reduction of the interval for the second dose of Covishield vaccine to eight weeks for individuals over 50 years of age and those having comorbidities. The gap between two doses of Covishield vaccine is presently 12 to 16 weeks.
The PIL was filed by Dr Siddharth De through Advocate Kuldeep Jauhari.
However, a bench of Chief Justice DN Patel and Justice Jyoti Singh dismissed the plea noting,
"We are not inclined to issue notice. We will dismiss with costs."
"Several studies of vaccine effectiveness have been conducted in the UK which indicates that a single dose of either vaccine is between 55 and 70% effective against the symptomatic disease, with higher levels of protection against severe disease including hospitalization and death. Additional protection is seen after a second dose. There is now also evidence from a number of studies that the vaccines are effective at protecting against infection and transmission."
" You are unable to convince us. Just for the sake of arguing you are arguing."
Jauhari further claimed that the petition was an honest PIL, the court responded that it had no doubt regarding the honesty of the plea and dismissal was not a certificate of dishonesty. It noted,
"Let alone issuance of a notice; we are inclined to dismiss the petitions with costs."
Sanchari Chattopadhyay has pursued her M.A in English and Culture Studies from the University of Burdwan, West Bengal. She likes observing cultural specificities and exploring new places.